stockrowSarepta Therapeutics, Inc.
SRPT Healthcare Biotechnology
Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024.
- Revenue
- −4.51%
- EPS
- +46.0%
- Free cash flow
- +231.8%
- Total debt
- −17.2%
Quarter to September 2026, against a year earlier
Follow SRPT
Alert me
Sarepta Therapeutics, Inc. (SRPT) Book value per share
Sarepta Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 11.4×, down 29.1% from 16.1× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 14.4×. Over the past ten years it has ranged from 4.4× (fiscal 2022) to 16.1× (fiscal 2024); the current reading is higher than 64% of that period. Sarepta Therapeutics, Inc. ranks 57th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 11.4× | (29.10%) |
| FY2024 | 16.1× | 72.78% |
| FY2023 | 9.3× | 111.54% |
| FY2022 | 4.4× | (61.50%) |
| FY2021 | 11.4× | 16.87% |
| FY2020 | 9.8× | (12.08%) |
| FY2019 | 11.1× | (28.67%) |
| FY2018 | 15.6× | 16.12% |
| FY2017 | 13.4× | 94.07% |
| FY2016 | 6.9× | 53.61% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 14.4× | (0.40%) |
| Jun 2026 | 14.5× | 1.08% |
| Mar 2026 | 14.3× | 25.84% |
| Dec 2025 | 11.4× | (13.50%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | 18.4× |
| SRPT Sarepta Therapeutics, Inc. | 14.4× |
| MAZE Maze Therapeutics, Inc. compare | 7.7× |
| VIR Vir Biotechnology, Inc. compare | 5.3× |
| TRAX First Tracks Biotherapeutics, Inc. compare | 4.2× |
| MRVI Maravai LifeSciences Holdings, Inc. compare | 2.3× |
| TRVI Trevi Therapeutics, Inc. compare | 2.1× |
| REPL Replimune Group, Inc. compare | 1.9× |
| MESO Mesoblast Limited compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))